Mylan offers EC concessions to get approval for $7.2 bln Meda buy

BRUSSELS, June 30 - U.S. generic drugmaker Mylan NV

has offered concessions in a bid to allay concerns by EU

competition regulators over its proposed $7.2-billion

acquisition of Swedish rival Meda,...

Read more